Neuropathic pain treatment market was valued at $10.9 billion in 2025 and is projected to reach $19.2 billion by 2035, growing at a CAGR of 5.8% during the forecast period (2026–2035). The increasing global burden of chronic diseases, particularly diabetes and cancer, is significantly driving demand for neuropathic pain therapies. Neuropathic pain arises from nerve damage and is often chronic and difficult to treat, requiring long-term therapeutic management through pharmacological and non-pharmacological approaches. The growing aging population, coupled with the rising prevalence of nerve-related disorders, is further accelerating the demand for effective treatment solutions.

Macular degeneration treatment market was valued at $18.8 billion in 2025 and is projected to reach $33.7 billion by 2035, growing at a CAGR of 6.0% during the forecast period (2026–2035). The increasing global burden of age-related vision impairment, particularly among the aging population, is significantly driving demand for effective macular degeneration treatments. According to data from the National Institutes of Health (NIH), approximately 2.2 billion people globally suffer from vision impairment or blindness, with age-related macular degeneration (AMD) being a leading cause among individuals aged 60 years and above. This rising prevalence is accelerating the adoption of advanced therapeutic interventions, including anti-VEGF therapies and emerging biologics, thereby strengthening market growth.

Large caliber ammunition market was valued at $14.50 billion in 2025 and is projected to reach $26.31 billion by 2035, growing at a CAGR of 6.1% during the forecast period (2026–2035). The rising geopolitical tensions and increasing defense modernization programs across major economies are significantly strengthening demand for large-caliber ammunition. Governments globally are increasing military budgets to enhance combat readiness, territorial security, and deterrence capabilities, driving procurement of advanced artillery, tank, and naval ammunition systems. Large caliber ammunition plays a critical role in long-range strike capabilities, firepower superiority, and operational effectiveness, thereby supporting sustained demand across land, naval, and air defense platforms.

IoT node and gateway market is projected to grow from $85 billion in 2025 to $183 billion by 2035, expanding at a CAGR of 8.0% during the forecast period. The market growth is primarily driven by the rapid expansion of connected infrastructure and industrial digitalization. Among hardware segments, Connected Integrated Circuits (ICs) are witnessing the fastest growth due to their critical role in enabling wireless communication (Wi-Fi, Bluetooth, LPWAN, 5G) across IoT ecosystems. Increasing demand for low-power connectivity and edge intelligence is driving innovation and strategic developments in this segment. From an application standpoint, the proliferation of smart energy systems and electric mobility is further reinforcing the need for IoT hardware. According to the International Renewable Energy Agency, renewable energy capacity additions reached over 500 GW globally in 2023, requiring advanced monitoring systems enabled by IoT nodes and gateways.

Incubator devices market was valued at $3.82 billion in 2025 and is projected to reach $7.19 billion by 2035, growing at a CAGR of 6.5% during the forecast period (2026–2035). The market growth is primarily driven by the rising global burden of preterm births and increasing demand for advanced laboratory research infrastructure. According to the World Health Organization (WHO), an estimated 15 million babies are born preterm every year globally, accounting for more than 1 in 10 births. This has significantly increased the need for technologically advanced neonatal incubators capable of providing controlled thermal environments, thereby supporting survival rates and neonatal care outcomes.

Immune-mediated inflammatory disease (IMID) treatment market was valued at $121.0 billion in 2025 and is projected to reach $191.04 billion by 2035, growing at a CAGR of 4.67% during the forecast period (2026–2035). The rising global burden of chronic inflammatory and autoimmune diseases, coupled with increased adoption of biologics and targeted therapies, is significantly driving market expansion. Governments and healthcare systems are increasingly prioritizing early diagnosis and long-term disease management to reduce disability and healthcare costs associated with IMIDs. Advanced biologics and targeted synthetic DMARDs are playing a critical role in improving patient outcomes by offering higher efficacy, reduced disease progression, and personalized treatment approaches.

Glider aircraft market was valued at $580 million in 2025 and is projected to reach $910 million by 2035, growing at a CAGR of 4.6% during the forecast period (2026–2035). The rising emphasis on sustainable and low-emission aviation is emerging as a key macro driver supporting market expansion. Governments and aviation authorities are increasingly promoting eco-friendly flight training and recreational aviation activities, where gliders offer a zero-emission alternative to powered aircraft. With no onboard fuel consumption during flight, gliders align with global decarbonization goals and are gaining traction across pilot training institutions, sports aviation communities, and tourism operators.

Gas analyzer market was valued at $4.05 billion in 2025 and is projected to reach $7.51 billion by 2035, growing at a CAGR of 6.36% during the forecast period (2026–2035). The increasing enforcement of environmental regulations and industrial emission standards is a key factor driving demand for advanced gas analysis solutions across industries. Governments globally are strengthening policies to monitor and control air pollution, greenhouse gas emissions, and workplace safety, thereby accelerating the adoption of gas analyzers in industrial automation applications.

The global fiberglass market was valued at $26.1 billion in 2025 and is projected to reach $47.9 billion by 2035, growing at a CAGR of 6.2% during the forecast period (2026–2035). The market growth is primarily driven by the rapid expansion of the construction and infrastructure sector globally, supported by increasing urbanization and government-led investments in sustainable and energy-efficient building materials. Fiberglass, known for its high strength-to-weight ratio, corrosion resistance, and thermal insulation properties, is widely used in reinforced composites, insulation systems, and structural applications, making it a critical material in modern infrastructure development.

Cytotoxic drugs market was valued at $20.32 billion in 2025 and is projected to reach $36.21 billion by 2035, growing at a CAGR of 5.95% during the forecast period (2026–2035). The increasing global burden of cancer is significantly driving demand for cytotoxic drugs, which remain a cornerstone in chemotherapy-based treatment regimens. Rising incidence rates of solid tumors and hematological malignancies, combined with expanding access to oncology care, are reinforcing the adoption of cytotoxic therapies across both developed and emerging markets. Despite the growing shift toward targeted therapies, cytotoxic drugs continue to play a critical role due to their broad-spectrum efficacy and cost-effectiveness.